000			03426nam a22003855i 4500
001			84702
003			ES-MaUEC
005			20230207040436.0
007			cr nn 008mamaa
008			151210s2016 gw | s |||| 0|eng d
020			_a9783319205380
040			_aES-MaUEC
050		4	_aRC848.F3 _b2016 EB
082	0	4	_a616.33
245	1	0	_aAlcoholic and Non-Alcoholic Fatty Liver Disease : _bBench to Bedside _cedited by Naga Chalasani, Gyongyi Szabo
260			_aCham _bSpringer International Publishing _c2016
300			_a1 recurso en línea (XVI, 372 páginas) _b47 ilustraciones, 36 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aEpidemiology and Risk Factors for Alcoholic Liver Disease -- Global Epidemiology and Risk Factors for Non-Alcoholic Fatty Liver Disease -- Pathogenesis of Alcoholic Liver Disease -- Pathogenesis of NAFLD and NASH -- Animal Models of Alcoholic Liver Disease -- Animal Models of Nonalcoholic Fatty Liver Disease -- Genetic Basis of Alcoholic and Nonalcoholic Fatty Liver Disease -- Clinical Features, Disease Modifiers and Natural History of Alcoholic Liver Disease -- Nonalcoholic Fatty Liver Disease (NAFLD): Clinical Features, Disease Modifiers, and Natural History -- Diagnostic Approaches and Clinical Endpoints of Treatment in Alcoholic Liver Disease -- Diagnostic Considerations and Clinical Endpoints for Nonalcoholic Steatohepatitis -- Pathology of Alcoholic and Non-Alcoholic Fatty Liver Disease -- Hepatic and Extra-Hepatic Malignancies in Alcoholic Liver Disease -- Hepatic and Extra-Hepatic Malignancies in NAFLD -- Treatment of Alcoholic Liver Disease Including Emerging therapies, Novel targets and Liver transplantation -- Current and Emerging Therapies for Non-Alcoholic Fatty Liver Disease -- Nonalcoholic Fatty Liver Disease in Children.
520	3		_aThis volume is the first text to concisely yet comprehensively cover developments for both alcoholic and non-alcoholic fatty liver disease in an organized fashion. Aspects of these two diseases covered in the book include global epidemiology and risk factors, pathogenesis, animal models, hepatic and extra-hepatic malignancies, treatment models, and current and emerging therapies. Written by experts in the field, Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside is a valuable resource for gastroenterologists, pathologists, and hepatologists who treat patients with alcoholic and nonalcoholic fatty liver disease.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aMedicina _0comprobar BNE19900959047 _2embne _9405021
650		7	_aGastroenterología _0comprobar BNE19900996790 _2embne _9141308
700	1		_aChalasani, Naga _eeditor literario _0Local _997080
700	1		_aSzabo, Gyongyi. _eeditor literario _997081 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-20538-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319205380
907			_a.b12939808 _b10-10-17 _c21-11-16
988			_aSpringer_Medicine_2016
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC848.F3 A436 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11584269 _z06-04-17
999			_c84702 _d84702 _x1